PCM
ATRA icon

Prelude Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Prelude Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,601
Closed -$631K – 1808
2021
Q4 		$631K Buy
+1,601
New +$674K 0.02% 870
2021
Q3 		– Sell
-3,191
Closed -$1.24M – 1730
2021
Q2 		$1.24M Sell
3,191
-362
-10% -$129K 0.04% 503
2021
Q1 		$1.28M Buy
+3,553
New +$1.57M 0.03% 516
2020
Q4 		– Sell
-4
Closed -$1K – 1293
2020
Q3 		$1K Buy
+4
New +$1.36K ﹤0.01% 1713
2018
Q4 		– Sell
-89
Closed -$92K – 1768
2018
Q3 		$92K Buy
+89
New +$87K 0.01% 977
2017
Q4 		– Sell
-529
Closed -$219K – 1355
2017
Q3 		$219K Buy
+529
New +$199K 0.02% 616

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return